Related Experiment Video

Updated: May 29, 2026

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

[Application of biotherapy in recurrent or metastatic gastric cancer]

Cheng-chao Shou, Ai-wen Wu

    Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery
    |August 26, 2011
    PubMed

    Insights

    Biotherapy shows promise for treating gastric cancer recurrence and metastasis, but personalized strategies are needed due to patient and tumor diversity. Further research is essential for effective biotherapy in gastric cancer treatment.

    Area of Science:

    • Oncology
    • Immunotherapy
    • Gastrointestinal Cancer Research

    Background:

    • Post-operative recurrence and metastasis are primary causes of mortality in gastric cancer patients.
    • Cancer cell biology and patient immune status significantly influence recurrence and metastasis.
    • Biotherapy offers targeted treatment options with demonstrated efficacy in various cancers, including gastric cancer recurrence.

    Discussion:

    • Current biotherapy strategies for gastric cancer recurrence lack ideal personalization due to high variability in clinical presentation, patient condition, and tumor characteristics.
    • The development of effective biotherapy requires addressing the heterogeneity of gastric cancer to optimize treatment outcomes.
    • Significant advancements are needed to tailor biotherapy for preventing and treating gastric cancer recurrence and metastasis.

    Key Insights:

    • Biotherapy demonstrates potential in managing gastric cancer recurrence and metastasis.
    • Patient and tumor heterogeneity present a major challenge for establishing universal biotherapy protocols.
    • Targeted and individualized biotherapeutic approaches are crucial for improving patient survival rates.

    Outlook:

    • Further basic research and clinical trials are necessary to refine biotherapy for gastric cancer.
    • Developing personalized biotherapy strategies will be key to overcoming treatment resistance and improving outcomes.
    • Future research should focus on understanding the complex interplay between tumor biology and the immune system to enhance biotherapy efficacy.

    More Related Videos

    Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

    Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

    Published on: May 10, 2024

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Cancer Therapies02:49

    Cancer Therapies

    Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
    However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Peptic Ulcer Disease IV: Management01:26

    Peptic Ulcer Disease IV: Management

    Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
    The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
    Pharmacological management
    The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
    Gastritis III: Clinical Manifestations and Management01:23

    Gastritis III: Clinical Manifestations and Management

    The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
    Clinical manifestations of acute gastritis
    The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...